Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.

Saved in:
Bibliographic Details
Title: Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.
Authors: Tajima K; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Hosonuma M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Funayama E; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan., Isobe J; Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan., Baba Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Murayama M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Narikawa Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Toyoda H; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Orthopedic Surgery, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Tsurui T; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Maruyama Y; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Sasaki A; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Amari Y; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Department of Otolaryngology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan., Yamazaki Y; Department of Toxicology, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan., Nakashima R; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Shida M; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Sasaki A; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Sambe T; Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Wada S; Division of Medical Oncology, Department of Medicine, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tsuji M; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Kiuchi Y; Department of Pharmacology, Showa Medical University Graduate School of Medicine, Tokyo, Japan.; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Kobayashi S; Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Kuramasu A; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa Medical University Graduate School of Medicine, Tokyo, Japan., Mori M; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Koyanagi K; Department of Gastroenterological Surgery, Tokai University School of Medicine, Kanagawa, Japan., Yoshimura K; Department of Clinical Immuno Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan.; Division of Medical Oncology, Department of Medicine, Showa Medical University Graduate School of Medicine, Tokyo, Japan.
Source: International journal of cancer [Int J Cancer] 2025 Sep 01; Vol. 157 (5), pp. 993-1005. Date of Electronic Publication: 2025 Jun 06.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0215
DOI:10.1002/ijc.35472